Physician profile
David A Edelman
NPI 1568663508
$23,485.02
in general payments reported to CMS, 2019-2025
21 companies · $230 in 2025
The $230 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,748 · 2020: $269 · 2021: $4,600 · 2022: $4,773 · 2023: $2,250 · 2024: $2,616 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,646 · Food and Beverage: $2,450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,645.61 |
| Food and Beverage | $2,450.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $16,158.42 | 2019-2023 | Da Vinci Surgical System |
| Tela Bio, INC. | $1,815.16 | 2019-2024 | Ovitex 2s |
| Acell, INC. | $1,583.14 | 2019 | |
| Progenacare Global, LLC | $820.52 | 2023 | |
| Ethicon US, LLC | $689.23 | 2019-2025 | Enseal X1, Echelon Circular, Echelon Endopath |
| Integra Lifesciences Corporation | $644.95 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kerecis Limited | $425.43 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Cook Incorporated | $355.92 | 2019 | |
| Aroa Biosurgery Incorporated | $149.91 | 2024 | |
| Depuy Synthes Sales INC. | $143.92 | 2023 | Matrixrib |
| Alexion Pharmaceuticals, INC. | $124.16 | 2021 | |
| Tetraphase Pharmaceuticals, INC. | $119.42 | 2019 | |
| Davol INC. | $109.05 | 2021 | |
| Kls-Martin L.P. | $75.01 | 2019 | |
| Bioventus LLC | $66.94 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $55.46 | 2019 | |
| W. L. Gore & Associates, INC. | $46.24 | 2021 | |
| Smith+Nephew, INC. | $31.83 | 2025 | Pico 7 |
| Polynovo North America LLC | $27.22 | 2025 | Novosorb Btm |
| Allergan, INC. | $24.40 | 2020 | |
| Medtronic, INC. | $18.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Edelman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.